S100P antibody-mediated therapy as a new promising strategy for the treatment of pancreatic cancer

Despite progresses in diagnosis and treatment, pancreatic cancer continues to have the worst prognosis of all solid malignant tumors. Recent evidences suggest that the metastasis-promoting protein S100P stimulates pancreatic tumor proliferation, survival, invasion and metastasis progression through...

Descripción completa

Detalles Bibliográficos
Autores principales: Dakhel, S, Padilla, L, Adan, J, Masa, M, Martinez, J M, Roque, L, Coll, T, Hervas, R, Calvis, C, Messeguer, R, Mitjans, F, Hernández, J L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038391/
https://www.ncbi.nlm.nih.gov/pubmed/24637492
http://dx.doi.org/10.1038/oncsis.2014.7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038391/
https://www.ncbi.nlm.nih.gov/pubmed/24637492
http://dx.doi.org/10.1038/oncsis.2014.7

Ejemplares similares